JHL Biotech Completes Wuhan Manufacturing Facility Construction

JHL Biotech, a Taiwan and China biotech, has completed the mechanical construction of its Wuhan biotech manufacturing facility, located in Biolake Park. The facility is a prefabricated building made by GE Healthcare, which was assembled in eleven days. JHL will use the Wuhan facility for cell line development, process development, and cGMP manufacturing of its late-stage clinical and commercial products. The company will also offer contract manufacturing on a limited basis. More details.... Stock Symbol: (TPEX: 6540) (NYSE: GE) Share this with colleagues: // //